Subsidised health services, health treatment provided by the Egyptian government for incapable citizens in Egypt, have increased by 28.2% during November, according to the Egyptian Cabinet’s Information and Decision Support Centre (IDSC).
According to state-owned news agency MENA, the subsidised health services surged from EGP 255.6m during October to reach EGP 327.8m last month. In November 2013, subsidised health services registered EGP 267.8m, marking a 22.4% year-on-year increase.
The value of treatments abroad declined this November, IDSC highlighted.
In October, the subsidised health care services for patients that required treatment abroad were valued at EGP 1.687m. In November, the value of treatments abroad registered EGP 841,000, declining by 50.1% compared to the previous month.
Over 171,000 patients were treated in Egypt, increasing by 26.2% compared to the preceding month. The number of patients who received treatment abroad was approximately 8 patients, a 27.3% drop compared to October.
Last July, the Egyptian government closed signed a memorandum of understanding (MOU) with American pharmaceutical company Gilead Sciences to supply the company’s Hepatitis C treatment Sovaldi at 1% of its original price.